WuXi Biologics
Offering End-to-End Solutions
Discovery Overview
WuXi Biologics offers industry-leading expertise, state-of-the-art facilities, and multiple antibody generation technology platforms for the discovery of novel monoclonal, bispecific and multispecific antibodies, immunocytokines and other biologics. We tailor solutions to best suit your technical and budget requirements and to ensure you achieve your key drug development milestones. Our antibody discovery team comprises about 400 highly-trained scientists for the generation, selection, optimization, and characterization of antibodies or other biologic molecules utilizing advanced in vitro and in vivo approaches. Based on your R&D goals, we customize a program that will advance your project from concept to IND filing. We also offer modular service and flexible business models.
WuXi Biologics enable clients to advance projects
from concept to commercialization
Integrated End-To-End Discovery Services
Target (Concept)
Lead Optimization & Characterization
IND Filing Support
Customized Featured Services
The Choice is Yours
mAb Discovery
Bispecific Antibody
Lead Optimization
In Vitro Characterizations
Scientists
Countries and Regions Served
Integrated Discovery Projects
Clinical Stage
Approved
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?